Welcome to our dedicated page for Bed Bath & Beyond SEC filings (Ticker: BBBY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bed Bath & Beyond, Inc. (NYSE: BBBY) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and related exhibits. These filings offer detailed insight into Bed Bath & Beyond’s strategy as an ecommerce-focused "Everything Home" company with home retail brands and a blockchain asset portfolio.
In its Form 8-K filings, Bed Bath & Beyond reports on a range of material events. These include merger and acquisition agreements, such as the Agreement and Plan of Merger under which a wholly owned subsidiary of Bed Bath & Beyond will merge with The Brand House Collective, Inc., subject to customary closing conditions. The filing describes the exchange ratio, treatment of equity awards, conditions to closing, termination rights, and potential termination fees, giving investors a structured view of the proposed transaction.
Other 8-Ks detail credit and financing arrangements, including an Amended and Restated Term Loan Credit Agreement and subsequent amendments with The Brand House Collective, delayed-draw term loan commitments that are convertible into equity, and additional commitments disclosed in later amendments. Filings also describe Bed Bath & Beyond’s participation in loans issued by The Container Store, Inc. via participation agreements, outlining aggregate purchase prices and the rights to interest and repayment associated with these positions.
Capital markets actions are another key focus of the company’s SEC disclosures. Bed Bath & Beyond has filed materials related to a warrant dividend distribution to shareholders, including a Warrant Agreement, registration statements for shares issuable upon exercise of the warrants, and detailed terms covering exercise price, expiration, early expiration conditions, and listing applications for the warrants under the ticker BBBY WS.
Filings further cover corporate governance and compensation matters, such as the adoption of the 2025 Employment Inducement Equity Incentive Plan under NYSE Rule 303A.08, and the appointment of Marcus Lemonis as Chief Executive Officer in addition to his role as Executive Chairman and principal executive officer. Results of operations and financial condition are furnished through earnings-related 8-Ks, which reference press releases and presentations with quarterly financial data and key operating metrics.
On Stock Titan, these filings are updated as they are released on EDGAR. AI-powered summaries help explain the significance of each document, from merger agreements and credit amendments to warrant distributions and executive appointments, so users can more quickly understand how each filing relates to Bed Bath & Beyond’s home-focused retail, services, and blockchain strategy.
Bed Bath & Beyond, Inc. announced the adoption of its 2025 Employment Inducement Equity Incentive Plan. The plan reserves a maximum of 1,500,000 shares of common stock for equity-based awards.
Adopted without stockholder approval under NYSE Rule 303A.08, the plan permits non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. Grants may be made only as “employment inducement” awards and must be approved by a majority of Independent Directors or the Compensation Committee composed solely of Independent Directors.
The Vanguard Group filed Amendment No. 8 to Schedule 13G reporting beneficial ownership of 3,732,108 shares of Bed Bath & Beyond Inc. common stock, representing 6.5% of the class as of September 30, 2025.
Vanguard reports 0 shares with sole voting power and 342,440 with shared voting power. It has 3,368,994 shares with sole dispositive power and 363,114 with shared dispositive power. The filing identifies Vanguard as an investment adviser and states the securities were acquired and are held in the ordinary course, not to change or influence control.
Vanguard notes its clients, including registered investment companies and other managed accounts, may receive dividends or sale proceeds related to these securities, and no other single person’s interest exceeds five percent.
Bed Bath & Beyond, Inc. (BBBY) reported Q3 results for the period ended September 30, 2025. Net revenue was $257.2 million, down 17% year over year, as orders fell and average order value rose slightly. Gross margin improved to 25.3% from 21.2%, keeping gross profit roughly flat at $65.2 million. Operating loss narrowed to $(12.5) million from $(45.2) million, and net loss improved to $(4.5) million (basic and diluted EPS $(0.07)) from $(61.0) million.
Expenses declined across sales and marketing, technology, and G&A, reflecting tighter spending. Cash and cash equivalents were $167.4 million as of September 30, 2025. The company raised $101.7 million net by selling 12,432,021 shares under its at‑the‑market program, repurchased $4.9 million in Q3 and $6.2 million year to date, and had $63.7 million remaining on its repurchase authorization.
Strategic brand moves included acquiring buybuy BABY IP for $7.1 million, purchasing the Kirkland’s brand for $12.9 million, and recognizing a $5.0 million gain from selling Bed Bath & Beyond trademarks in Canada/UK. Subsequent event: a warrant dividend of one warrant per ten shares, exercisable at $15.50 and expiring on October 7, 2026, subject to early‑expiration conditions.
Bed Bath & Beyond, Inc. reported that it issued a press release with financial results for the three and nine months ended September 30, 2025. The company furnished the release as Exhibit 99.1 and posted an updated investor presentation in the Events & Presentation section of its investor relations site.
The information provided under Item 2.02 and in Exhibit 99.1 is furnished and not deemed filed under the Exchange Act.
BlackRock, Inc. filed Amendment No. 5 to Schedule 13G reporting beneficial ownership of 4,123,240 shares of Bed Bath & Beyond, Inc. common stock, representing 7.2% of the class as of 09/30/2025. BlackRock reported sole voting power over 4,025,167 shares and sole dispositive power over 4,123,240 shares, with no shared voting or dispositive power.
BlackRock certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing is signed by a Managing Director and includes a Power of Attorney exhibit.
Bed Bath & Beyond, Inc. is registering up to 6,884,548 shares of common stock for issuance upon exercise of newly distributed warrants. The company’s board approved a warrant dividend so that stockholders of record on October 2, 2025 receive one warrant for every ten common shares, with each warrant allowing the purchase of one share at a cash exercise price of $15.50 starting after a related Form S-3 becomes effective. The warrants are scheduled to expire on October 7, 2026, but this date can automatically move earlier if specified volume-weighted average price conditions are met, and the company may set an alternate expiration date subject to additional price tests. The company has applied to list the warrants on the New York Stock Exchange under the symbol “BBBY WS” and describes anti-dilution adjustments that can change the number of shares issuable per warrant.
Bed Bath & Beyond, Inc. is registering up to 6,884,548 shares of its common stock to cover issuances upon exercise of transferable warrants distributed to holders of Common Stock as of the Record Date. The Company distributed one Warrant for every ten shares outstanding and set an initial cash exercise price of $15.50 per Warrant. Unless earlier accelerated under the Warrant Agreement, Warrants are exercisable from the effectiveness of this registration statement through October 7, 2026. If all Warrants issued were exercised, the Company would have 75,730,029 shares outstanding after the exercise period. The Warrants are expected to trade on the NYSE under the ticker BBBY WS, but no assurance of an orderly market is provided. Proceeds from cash exercises will be received by the Company. The prospectus highlights customary risk factors, tax considerations for U.S. holders including basis allocation rules, potential anti-dilution adjustments that could create constructive distributions, indemnification provisions for directors and officers, and incorporation by reference to prior SEC filings and audited financial statements.
Jane Street disclosed collective ownership of 2,910,102 shares of Bed Bath & Beyond common stock, representing 5.1% of the class as of the 09/30/2025 event date. The filing lists four related reporting entities — Jane Street Group, LLC, Jane Street Capital, LLC, Jane Street Options, LLC, and Jane Street Global Trading, LLC — each organized in Delaware and sharing voting and dispositive power over the reported positions. Individual holdings reported are 2,200,000 shares by Jane Street Global Trading, 647,900 by Jane Street Options, and 62,202 by Jane Street Capital, with the parent aggregation at 2,910,102 shares. The filing certifies the shares were not acquired to change or influence control.
Bed Bath & Beyond, Inc. filed an 8-K noting it issued a press release and posted supplemental FAQs about its previously announced warrant dividend distribution to shareholders of common stock as of the October 2, 2025 record date. These supplemental FAQs update and, where different, supersede an earlier set of FAQs about the warrant distribution.
The company explains that warrants will be issued as a distribution for no consideration, and that this issuance has not been registered under the Securities Act because such a free distribution is not treated as a sale. A Form 8-A registration statement and a prospectus supplement describing the warrant terms will be filed with the SEC and made available on the SEC’s website, and holders are directed to read the prospectus supplement and, when available, the warrant agreement, which will govern their rights. The filing also includes forward-looking statements about the anticipated distribution, possible gross proceeds from warrant exercises, expected use of those proceeds, and potential trading of the warrants on the New York Stock Exchange, noting these are subject to various risks and uncertainties.
Bed Bath & Beyond, Inc. updated its dealings with The Brand House Collective, Inc. on September 15, 2025. The company amended its existing term loan credit agreement to add new delayed-draw term loan commitments with an aggregate original principal amount of $20 million, which the company can convert into equity of The Brand House Collective, up to 75% of its outstanding common stock, under agreed conditions.
The company also amended its asset purchase agreement for the Kirkland’s brand, increasing the total purchase price from $5.233 million to $10 million for trademarks, domain names, and related brand assets, paid at closing on September 15, 2025. At the same time, Bed Bath & Beyond amended the existing trademark license so The Brand House Collective can continue using the Kirkland’s brand for its current stores, websites, and products, including an exclusive license for existing brick-and-mortar stores that lasts until the earlier of September 15, 2027 or the rebranding or closure of all such stores.